X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-17 | BDTX | Biotech Growth N V | 10% | P - Purchase | $2.34 | +400,000 | 8,517,839 | +5% | +$934,080 | ||||||
2023-06-30 | BDTX | Biotech Growth N V | 10% | P - Purchase | $5.00 | +1,000,000 | 8,117,839 | +14% | +$5,000,000 | ||||||
2023-06-27 | BDTX | Biotech Growth N V | 10% | P - Purchase | $5.49 | +1,740,000 | 7,117,839 | +32% | +$9,555,036 | ||||||
2022-10-31 | BDTX | Biotech Growth N V | 10% | P - Purchase | $2.25 | +99,801 | 5,377,839 | +2% | +$224,912 | ||||||
M | 2022-10-27 | BDTX | Biotech Growth N V | 10% | P - Purchase | $2.02 | +364,652 | 5,278,038 | +7% | +$736,186 | |||||
M | 2022-10-26 | EPIX | Biotech Growth N V | 10% | P - Purchase | $4.11 | +2,000,000 | 7,879,583 | +34% | +$8,219,600 | |||||
2022-10-21 | BDTX | Biotech Growth N V | 10% | P - Purchase | $1.51 | +87,850 | 4,913,386 | +2% | +$132,750 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |